Related Blog Posts
Emerging Markets in the Pharmaceutical Industry Latest News, Computers and Technology, Discussions and More | MJLBlog.com
18 hours ago ago from Latest News, Computers and Technology, Discussions and More | MJLBlog.com
Home Discussions Latest News, Computers and Technology, Discussions and More | MJLBlog.com Brought to you by: MJLComputer.com Comments By Email RSS The First Law of CircleNomics Social Media Workflow Emerging Markets in the Pharmaceutical Industry ...
Related contentCool Technology for Pharmacy
4 hours ago ago from Jerry Fahrni
My Cool Technology for Pharmacy this week strays a little from my normal hardware and software approach and focuses on the concept of RxNorm. The reason for this deviation is simple; my ignorance of RxNorm was never more evident than during my time at ASHP Midyear this week. I don’t like it when I lack understanding of what people are talking about, and this happened on a couple of occasions during discussions involving RxNorm. This was ...
Related contentLearn More Info About Phentermine 37.5 in Blog Publication
7 hours ago ago from A Beauty Place
Is the name of a preparation of the trade mark the general brand? It is a question which we can appear to ask from time to time. What is cheaper? What is more effective? What core is better? We will hope well, that this article will help to clear any few messes and will educate you about what will be better for you So you really wish to know, what is better? As how I speak what are safe and effective? Do you trust? Well, it is the truth. ...
Related contentFrom "Big Pharma's Bitter Pill" by Terrance Heath
21 hours ago ago from PharmaGossip
Drug companies were rated the third most profitable industry in the U.S. in 2007 by Fortune magazine. In 2007 alone, the top 12 drug makers reaped combined profits of $78,600,000,000 (billion). The industry's most profitable member , Novartis, netted $11,900,000,000 (billion) in 2007, 67 percent more than in 2006. Pharmaceutical companies have plenty of revenues to cover R&D for a very long time . In 2004, drug makers spent, on average, ...
Related contentWhen Pharmaceutical Corporate Criminals Rule: the Advocates will Betray Us, the Doctors Will Lie to Us, and We All Will Swallow the Bitter Poison Pill
13 hours ago ago from Is Something Not Quite Right With Stan - A Mental Health Blog
When Pharmaceutical Corporate Criminals Rule: the Advocates will Betray Us, the Doctors Will Lie to Us, and We All Will Swallow the Bitter Poison Pill Why isn't anything (or at best very little) being done to stop the lies and crimes? There are no magic answers or silver bullets when it comes to answering this question. The behaviors are so ingrained and meshed into the fabric of are lives and society that the steps that will have ...
Related contentRelated News
Lotus Pharmaceuticals, Inc. Appoints OTC Division Head
19 hours ago ago from PopEater
BEIJING , Dec. 10 /PRNewswire-Asia/ -- Lotus Pharmaceuticals, Inc. (OTC Bulletin Board: LTUS) ("Lotus" or the "Company") a growing developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People's Republic of China ("PRC"), today reported that effective December 1, 2009 , Liang Fang , a controlled operating entity of Lotus, appointed Mr. Jinzhong HAN to be General Manager of the Company's ...
Related contentSenate Tied in Knots Over Proposal to Allow Imported Drugs
6 hours ago ago from The New York Times
WASHINGTON Debating an overhaul of the health care system, the Senate found itself tied in knots on Thursday over a bipartisan proposal to allow people to import lower-cost prescription drugs from Canada and certain other countries. A blog from The New York Times that tracks the health care debate as it unfolds. More Health Care Overhaul News Health Care Conversations Share your thoughts about the health ...
Related contentNymox Pharmaceuticals gets $15M financing deal
12 hours ago ago from PopEater
HASBROUCK HEIGHTS, N.J. -Drug developer Nymox Pharmaceutical Corp. said Thursday it has obtained a commitment for $15 million in equity financing from institutional investors. The money will be used for general corporate purposes. The financing also will help the company continue with research into new drugs including one called NX-1207, which may treat an enlarged prostate. The investors may get common stock at a 3 percent discount to the ...
Related contentEli Lilly Ups 2010 Earnings Forecast - FOXBusiness.com
15 hours ago ago from FOX Business
Existing users please login User Name: Password: Remember me on this computer Home / Markets / Industries / Health Care Thursday, December 10, 2009 Eli Lilly Ups 2010 Earnings Forecast  By Ken Sweet FOXBusiness  Drug maker Eli Lilly ( LLY ) raised its ...
Related contentEli Lilly predicts earnings growth, touts pipeline
16 hours ago ago from U.S. News
Eli Lilly predicts earnings growth, touts pipeline INDIANAPOLIS (AP) -- Eli Lilly & Co. said Thursday earnings per share could grow more than 10 percent next year, but the drugmaker's stock dipped as its 2009 forecast fell short of Wall Street expectations. Indianapolis-based Lilly also touted its pipeline of drugs under development during a Webcast of its annual meeting with investors in New York. Company leaders said they expect to launch ...
Related content
